The European Partnership for Personalised Medicine, EP PerMed, offers the opportunity for international cooperation in personalised medicine. In December 2024, the partnership opens a call for proposals (JTC 2025) with a focus on developing more accurate tools so that healthcare providers can take into account the importance of genes in how we react to drugs, so called pharmacogenomics. Vinnova funds Swedish participation in the call. The application procedure is carried out in two stages. First you apply with a pre-proposal, in the next step with a full proposal. See the original international call text at www.eppermed.eu and in the attached PDF.
Plesae download the templates you need to attach to your application such as a CV or project description. Below you can also find any attachments with useful information for your application.
Internationell annonseringstext (pdf, 439 kB)As soon as this offer opens for the application, we will publish complete information. We will describe, for example, what you can apply for, how much you can apply for and what we assess your application for.
To apply for funding from us, you need to fill in a longer application, which we then assess in competition with others. If we decide to finance your project, you need to report to us how the project is going, so that we can see that you carry out the project as you described in the application.
You have chosen to disallow certain cookies and funtions on our website, such as registering for newsletters. You can change your privacy settings at any time to allow these functions and get a better experience.
Reference number 2024-04176
